Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds HSBC Maintains Hold on GLOBALFOUNDRIES, Raises Price Target to $65

HSBC Maintains Hold on GLOBALFOUNDRIES, Raises Price Target to $65

HSBC analyst Frank Lee maintains GLOBALFOUNDRIES (NASDAQ:GFS) with a Hold and raises the price target from $55 to $65.

byBenzinga Newsdesk

February 15, 2023

1 minute read

HSBC analyst Frank Lee maintains GLOBALFOUNDRIES (NASDAQ:GFS) with a Hold and raises the price target from $55 to $65.

Raymond James Upgrades Profound Medical to Strong Buy

By Benzinga Newsdesk

November 4, 2:55 PM

Raymond James analyst Rahul Sarugaser upgrades Profound Medical (NASDAQ:PROF) from Outperform to Strong Buy.

PROF

Goldman Sachs Initiates Coverage On Fate Therapeutics with Sell Rating, Announces Price Target of $10

By Benzinga Newsdesk

December 15, 6:46 AM

Goldman Sachs analyst Andrea Tan initiates coverage on Fate Therapeutics (NASDAQ:FATE) with a Sell rating and announces Price Target of $10.

FATE

Why Gambling.com’s Stock Is Getting Crushed Today

By Aaron Bry

November 16, 3:55 PM

Gambling.com Group’s (NASDAQ: GAMB) stock traded down more than 20% in Thursday’s session after the company released its earnings report before the open.

GAMB

Gold Bug Peter Schiff Warns Progress On Inflation Likely To Be Reversed As Dollar Index Falls To Over 1-Year Low

By Shanthi Rexaline

July 14, 8:15 AM

The dollar index, which measures the strength of the greenback against a basket of foreign currencies, broke below…

UUP

HSBC Maintains Hold on GLOBALFOUNDRIES, Raises Price Target to $65

Related Posts

Raymond James Upgrades Profound Medical to Strong Buy

Goldman Sachs Initiates Coverage On Fate Therapeutics with Sell Rating, Announces Price Target of $10

Why Gambling.com’s Stock Is Getting Crushed Today

Gold Bug Peter Schiff Warns Progress On Inflation Likely To Be Reversed As Dollar Index Falls To Over 1-Year Low